Keybanc Maintains Overweight on LifeStance Health Gr, Raises Price Target to $13

Benzinga Newsdesk www.benzinga.com Positive 83.3%

Neg 0% Neu 0% Pos 83.3%

Keybanc analyst Steve Dechert maintains LifeStance Health Gr (NASDAQ:LFST) with a Overweight and raises the price target from $11 to $13.